Dr. Taochao Tan

Dr.Taochao Tan, Executive Director for  R&D 

Dr. Tan joined IASO Biotherapeutics in 2018, and is currently the company’s Executive Director for Research & Development for Antibodies. Dr. Tan graduated with PhD of Biochemistry and Molecular Biology from Peking University. He is an expert in development technology for antibody drug including construction of human antibody library, antibody panning, antibody bio-activity identification and antibody protein engineering, among others. He has 6 antibody patents and 4 CAR-T patents under his name. Before joining IASO Biotherapeutics Dr. Tan was Head of Antibody R&D Department in Eureka Therapeutics, Inc., having completed dozens of therapeutic antibody research projects, some of which have entered the clinical stage.